Get started
Tourmaline Bio, Inc.TT

Tourmaline Bio, Inc.

16.84USDR
−0.28−1.64%
Last update at Mar 26, 23:41 GMT
15.20USD
−1.64−9.74%
No tradesPre-marketLast update at 08:00 GMT
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

TRML chart


Full chart

TRML upcoming earnings


Next report date
≈
May 19
Report period
Q1 2025
EPS estimate
−0.90 USD
Revenue estimate
0.00 USD

Key stats


Market capitalization
‪432.54 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.88 USD
Net income (FY)
‪−73.21 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪16.04 M‬
Beta (1Y)
1.84

About Tourmaline Bio, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Sandeep C. Kulkarni
Website
tourmalinebio.com
Headquarters
New York
Founded
2021
FIGI
BBG00NX995R3
Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006. The company was founded by Sandeep Kulkarni on September 17, 2021 and is headquartered in New York, NY.

Financials


Performance
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−24.00 M‬‬
‪‪−18.00 M‬‬
‪‪−12.00 M‬‬
‪‪−6.00 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−28.00 M‬‬
‪‪−21.00 M‬‬
‪‪−14.00 M‬‬
‪‪−7.00 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−24.00 M‬‬
‪‪−18.00 M‬‬
‪‪−12.00 M‬‬
‪‪−6.00 M‬‬
‪0.00‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−50.00 M‬‬
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:May 19, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪−1.00‬
‪−0.75‬
‪−0.50‬
‪−0.25‬
‪0.00‬
Actual
Estimate

TRML news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TRML is 16.84 USD — it has decreased by −1.64% in the past 24 hours. Watch Tourmaline Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tourmaline Bio, Inc. stocks are traded under the ticker TRML.
TRML stock has fallen by −1.67% compared to the previous week, the month change is a 32.05% rise, over the last year Tourmaline Bio, Inc. has showed a −30.15% decrease.
We've gathered analysts' opinions on Tourmaline Bio, Inc. future price: according to them, TRML price has a max estimate of 74.00 USD and a min estimate of 43.00 USD. Watch TRML chart and read a more detailed Tourmaline Bio, Inc. stock forecast: see what analysts think of Tourmaline Bio, Inc. and suggest that you do with its stocks.
TRML reached its all-time high on Jun 7, 2021 with the price of 198.20 USD, and its all-time low was 8.90 USD and was reached on Dec 28, 2022. View more price dynamics on TRML chart.
See other stocks reaching their highest and lowest prices.
TRML stock is 4.47% volatile and has beta coefficient of 1.84. Track Tourmaline Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Tourmaline Bio, Inc. there?
Today Tourmaline Bio, Inc. has the market capitalization of ‪439.73 M‬, it has decreased by −3.29% over the last week.
Yes, you can track Tourmaline Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Tourmaline Bio, Inc. is going to release the next earnings report on May 19, 2025. Keep track of upcoming events with our Earnings Calendar.
TRML earnings for the last quarter are −0.86 USD per share, whereas the estimation was −0.86 USD resulting in a −0.54% surprise. The estimated earnings for the next quarter are −0.90 USD per share. See more details about Tourmaline Bio, Inc. earnings.
Tourmaline Bio, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
TRML net income for the last quarter is ‪−22.23 M‬ USD, while the quarter before that showed ‪−20.18 M‬ USD of net income which accounts for −10.20% change. Track more Tourmaline Bio, Inc. financial stats to get the full picture.
Like other stocks, TRML shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tourmaline Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tourmaline Bio, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tourmaline Bio, Inc. stock shows the sell signal. See more of Tourmaline Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.